1800 244 735

Helpline (02) 9874 9777

Generation HD1 trial halted

Huntington’s Associations across Australia and the rest of the world have learned today that the Roche clinical trial called Phase III Generation HD1 has been halted, not by Roche, but by an independent data monitoring committee.

The detailed reasons for this decision are not yet available, but those participating on the trial of the drug (known as Tominersen) are being contacted individually by the research teams to let them know this tough news.

We, like you, are extremely disappointed by this decision as so many hopes were riding on a successful trial outcome for a new and effective drug. We know that Roche and its Australian research partners will be communicating more details as soon as they are available. Please remember however, that there are more trials underway, and more still in the pipeline.

HD research funding is high relative to the number of people with HD, as it is seen as a potential gateway to better understanding other neurological diseases.

While this doesn’t make today’s news any easier, please remember that both hope and work for a cure, or a way to prevent HD is a huge priority for a large body of researchers across many different countries and many research disciplines.

Here is a link to the statement put out by the Roche team.

If you would like to read some more head over to HD Buzz.

Share on facebook
Share on twitter
Share on pinterest
Share on email

Latest News and Stories

Update on research from Dr Therese Alting

Published date: 1 December, 2021

2021 has been a tough year, and for the HD community, it wasn’t just COVID-19. So many people around the world had their hopes pinned on the ground-breaking Huntingtin-lowering drug trials that were underway. Dr Therese Alting, board member of Huntington's NSW ACT and Clinical Neuropsychologist at Concord and Westmead Hospitals, gives an easy to read update.
Hoping Machine documentary by Charles Sabine

CHDI Foundation Postcards

Published date: 15 November, 2021

The Postcards are a series of short videos aimed at non-scientists that convey the major themes, scientific breakthroughs, and clinical trial updates from each year’s Huntington’s Disease.

Introducing Prof. Kenneth Serbin – guest speaker at AGM

Published date: 11 November, 2021

Kenneth P. Serbin’s mother Carol died of Huntington’s disease in 2006 after a 20-year battle against the disease. Serbin tested positive for the HD gene in 1999. His daughter Bianca tested negative for HD in the womb and is today a healthy 21-year-old college senior. Since 1998, Serbin has served as a volunteer advocate for ... Read more

HD Spotlight on Amy Hale

Published date: 2 November, 2021

Here from our Youth Social Worker, Amy Hale, on why she became a social worker, how she got involved in the HD world and what her ideal Sunday is.

HD News Spring 2021

Published date: 1 November, 2021

Download your copy of the HD News Spring 2021 here. We hope that you enjoy reading the latest news from Huntington's NSW ACT. If you have any feedback or questions please contact us at the office.
Carer opening a care hamper

Celebrating National Carers week

Published date: 28 October, 2021

Thank you @CarersNSW Our Carer Support groups received a donation from CarersNSW to help celebrate National Carers week (Sunday 10th Oct-Sat 16th Oct). Each region was planning to host an event for their Carer group but unfortunately COVID hijacked these plans. Instead carers of the Port Macquarie and Wollongong Support groups received a phone call, ... Read more